{"id":"W2801354368","doi":"10.1111/bjh.15232","title":"A tale of two antibodies: obinutuzumab <i>versus</i> rituximab","year":2018,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"Centers for Disease Control and Prevention","keywords":"Obinutuzumab; Rituximab; Medicine; CD20; Clinical trial; Immunology; Oncology; Context (archaeology); Dosing; Lymphoma; Internal medicine; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00112841,0.0005830067,0.001627906,0.002169645,0.0003461976,0.001358224,0.000906983,0.001596082,0.003865107],"category_scores_gemma":[0.001088877,0.0002882748,0.0006871177,0.001617236,0.0006115574,0.002325987,0.0007739615,0.002542391,0.001344364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009269543,"about_ca_system_score_gemma":0.001307493,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008804221,"about_ca_topic_score_gemma":0.001985824,"domain_scores_codex":[0.9996744,0.00007762924,0.00006016111,0.00005220805,0.0001024951,0.00003309718],"domain_scores_gemma":[0.9996111,0.0002253494,0.0000488062,0.00001131148,0.00007038475,0.00003302679],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000222024,0.00005648068,0.00012874,0.02756263,0.0001781631,0.0001897814,0.0001129541,0.0002269513,0.001992815,0.008026838,0.04268752,0.9186152],"study_design_scores_gemma":[0.00003995879,0.000131719,0.0004512193,0.009089277,0.0001547808,0.0009443622,0.00009254777,0.00005010177,0.0004253474,0.003610689,0.9849951,0.0000149249],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001346377,0.997943,0.00007165627,0.0009444224,0.0002642217,0.000004794467,0.00001184821,0.000005322845,0.0006201818],"genre_scores_gemma":[0.001260304,0.9964008,0.0001971634,0.001052082,0.000274513,0.00001006853,0.00002748744,0.00000307955,0.0007744188],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003865107,"threshold_uncertainty_score":0.01293004,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06548623625567729,"score_gpt":0.3994626126605701,"score_spread":0.3339763764048929,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}